𝛼SK or Search

ENTITY

Hua Medicine (2552 HK)

32

Analysis

Health Care • China

Hua Medicine is an innovative drug development and commercialization company focused on novel therapies for patients with unmet medical needs, particularly in diabetes care. Its cornerstone product is HuaTangNing (dorzagliatin tablets), a first-in-class oral drug for the treatment of Type 2 diabetes. The company was founded in 2011 and is headquartered in Shanghai, China.

more

Refresh

Exchange Announcement • 24 Sep 2026 21:38

Notification Letter To Non-Registered Shareholders And Request Form

Exchange Announcement • 24 Sep 2026 21:34

Notification Letter To Registered Shareholders And Reply Form

Exchange Announcement • 24 Sep 2026 16:36

Interim Report 2026

Exchange Announcement • 21 Aug 2026 19:35

Grant Of Share Options

Exchange Announcement • 20 Aug 2026 20:12

Interim Results Announcement For The Six Months Ended June 30, 2026

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x